Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis

Journal of Proteomics

Volumn 74, Issue 12, 2011, Pages 2826-2836

  Del Boccio, Piero ^a   Pieragostino, Damiana ^a   Di Ioia, Maria ^a   Petrucci, Francesca ^a   Lugaresi, Alessandra ^a   De Luca, Giovanna ^a   Gambi, Domenico ^a   Onofrj, Marco ^a   Di Ilio, Carmine ^a   Sacchetta, Paolo ^a   Urbani, Andrea ^b,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biomarker; Lipidomics; Mass spectrometry; Multiple sclerosis

Indexed keywords

BIOLOGICAL MARKER; GALACTOSYLCERAMIDE; MOLECULAR MARKER; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; ENCEPHALOMYELITIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; LIPID ANALYSIS; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; FEMALE; HUMANS; LIPID METABOLISM; LYSOPHOSPHATIDYLCHOLINES; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 81055156279     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.06.023     Document Type: Article

References (54)

1. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747. [Review].
2. Ramli N., Rahmat K., Azmi K., Chong H.T. The past, present and future of imaging in multiple sclerosis. J Clin Neurosci Apr. 2010, 17(4):422-427. [Epub 2010 Feb 18. Review].
3. Degenhardt A., Ramagopalan S.V., Scalfari A., Ebers G.C. Clinical prognostic factors in multiple sclerosis: a natural history review. Nat Rev Neurol Dec. 2009, 5(12):672-682.
4. Lublin F.D., Reingold S.C. Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology Mar. 1997, 48(3):572-574.
5. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
6. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999, 5:170-175.
7. Kanter J.L., Narayana S., Ho P.P., Catz I., Warren K.G., Sobel R.A., et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med Jan. 2006, 12(1):138-143.
8. Wheeler D., Bandaru V.V., Calabresi P.A., Nath A., Haughey N.J. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain Nov. 2008, 131(Pt 11):3092-3102.
9. Quintana F.J., Farez M.F., Viglietta V., Iglesias A.H., Merbl Y., Izquierdo G., et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA Dec. 2 2008, 105(48):18889-18894.
10. Wenk M.R. Lipidomics: new tools and applications. Cell Dec. 10 2010, 143(6):888-895.
11. Watson A.D. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res 2006, 47(10):2101-2111.
12. Adibhatla R.M., Hatcher J.F. Role of lipids in brain injury and diseases. Future Lipidol Aug. 2007, 2(4):403-422.
13. Olsson N.U., Harding A.J., Harxper C., Salem N. High-performance liquid chromatography method with light-scattering detection for measurements of lipid class composition: analysis of brains from alcoholics. J Chromatogr B 1996, 681:213-218.
14. Seppar̈nen-Laakso T., Laakso I., Vanhanen H., Kiviranta K., Lehtimar̈ki T., Hiltunen R. Major human plasma lipid classes determined by quantitative high-performance liquid chromatography, their variation and associations with phospholipid fatty acids. J Chromatogr B 2001, 754:437-445.
15. Rodríguez-Bernaldo de Quiro A., LoD́pez-HernaD́ndez J., Simal- Lozano J. Separation of phospholipid classes in sea urchin, paracentrotus lividus by high-performance liquid chromatography. J Chromatogr B 2002, 770:71-75.
16. Stith B.J., Hall J., Ayres P., Waggoner L., Moore J.D., Shaw W.A. Quantification of major classes of Xenopus phospholipids by high performance liquid chromatography with evaporative light scattering detection. J Lipid Res 2000, 41:1448-1454.
17. Holland W.L., Stauter E.C., Stith B.J. Quantification of phosphatidic acid and lysophosphatidic acid by HPLC with evaporative light-scattering detection. J Lipid Res Apr. 2003, 44(4):854-858.
18. Wilson R., Lyall K. Quantitative analysis of long-chain trans-monoenes originating from hydrogenated marine oil. Lipidology 2002, 37:917-924.
19. Murphy R.C. Mass spectrometry of lipids 1993, 71-282. Plenum Press, New York.
20. Han X., Gross R.W. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc Natl Acad Sci USA 1994, 91(22):10635-10639.
21. Han X., Gross R.W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res 2003, 44:1071-1079.
22. Wang W., Feng B., Li X., Yin P., Gao P., Zhao X., Lu X., Zheng M., Xu G. Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry. Mol Biosyst 2010 Oct, 6(10):1947-1955.
23. Sorensen C.M., Ding J., Zhang Q., Alquier T., Zhao R., Mueller P.W., et al. Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subset. Clin Biochem Aug. 2010, 43(12):948-956.
24. Han X., Jiang X. A review of lipidomic technologies applicable to sphingolipidomics and their relevant applications. Eur J Lipid Sci Technol 2009, 111(1):39-52.
25. Shevchenko A., Simons K. Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol Aug. 2010, 11(8):593-598.
26. Ekroos K., Jänis M., Tarasov K., Hurme R., Laaksonen R. Lipidomics: a tool for studies of atherosclerosis. Curr Atheroscler Rep Jul. 2010, 12(4):273-281.
27. Sandra H., Pereira K,., Ados S., Vanhoenacker G., David F., Sandra P. Comprehensive blood plasma lipidomics by liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr A Jun. 18 2010, 1217(25):4087-4099.
28. Graessler J., Schwudke D., Schwarz P.E., Herzog R., Shevchenko A., Bornstein S.R. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One Jul. 15 2009, 4(7):e6261.
29. Gross R.W., Han X. Lipidomics in diabetes and the metabolic syndrome. Methods Enzymol 2007, 433:73-90.
30. D'Aguanno S., Barassi A., Lupisella S., d'eril G.M., Del Boccio P., Pieragostino D., et al. Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis. J Neuroimmunol Jan. 2008, 193(1-2):156-160.
31. Mantini D., Petrucci F., Pieragostino D., Del Boccio P., Di Nicola M., Di Ilio C., et al. LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise. BMC Bioinformatics Mar. 2007, 26(8):101.
32. Del Boccio P., Pieragostino D., Lugaresi A., Di Ioia M., Pavone B., Travaglini D., et al. Cleavage of cystatin C is not associated with multiple sclerosis. Ann Neurol Aug. 2007, 62(2):201-204.
33. Pieragostino D., Petrucci F., Del Boccio P., Mantini D., Lugaresi A., Tiberio S., et al. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics Jan. 3 2010, 73(3):579-592.
34. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
35. Croset M., Brossard N., Polette A., Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000, 345:61-67.
36. Vernez L., Wenk M., Krähenbühl S. Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 2004, 18(11):1233-1238.
37. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
38. Löhmann C., Schachmann E., Dandekar T., Villmann C., Becker C.M. Developmental profiling by mass spectrometry of phosphocholine containing phospholipids in the rat nervous system reveals temporo-spatial gradients. J Neurochem Aug. 2010, 114(4):1119-1134.
39. Lieser B., Liebisch G., Drobnik W., Schmitz G. Quantification of sphingosine and sphinganine from crude lipid extracts by HPLC electrospray ionization tandem mass spectrometry. J Lipid Res Nov. 2003, 44(11):2209-2216.
40. Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 2000, 107:1027-1063.
41. Asaoka Y., Oka M., Yoshida K., Sasaki Y., Nishizuka Y. Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C. Proc Natl Acad Sci USA 1992, 89:6447-6451.
42. Liebisch G., Drobnik W., Lieser B., Schmitz G. High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clin Chem 2002, 48:2217-2224.
43. Okita M., Gaudette D.C., Mills G.B., Holub B.J. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients. Int J Cancer 1997, 71:31-34.
44. Fox L.M., Cox D.G., Lockridge J.L., Wang X., Chen X., Scharf L., et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 2009 Oct, 7(10):e1000228.
45. Gauster M., Rechberger G., Sovic A., Hörl G., Steyrer E., Sattler W., et al. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res Jul. 2005, 46(7):1517-1525.
46. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997, 23:134-147.
47. Kriat M., Vion-Dury J., Confort-Gouny S., Favre R., Viout P., Sciaky M., et al. Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J Lipid Res 1993, 34(6):1009-1019.
48. Kuliszkiewicz-Janus M., Janus W., Baczynski S. Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers. Anticancer Res 1996, 16(3B):1587-1594.
49. Kuliszkiewicz-Janus M., Tuz M.A., Baczynski S. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia. Biochim Biophys Acta 2005, 1737(1):11-15.
50. Sullentrop F., Moka D., Neubauer S., Haupt G., Engelmann U., Hahn J., et al. 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed 2002, 15(1):60-68.
51. Mulder C., Wahlund L.O., Teerlink T., Blomberg M., Veerhuis R., van Kamp G.J., et al. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease. J Neural Transm Aug. 2003, 110(8):949-955.
52. Hoekko S., Miller E., Dud E., Reaven P., Curtiss L.K., Zvaifler N.J., et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996, 98:815-825.
53. Winyard P.G., Tatzbar F., Esterbauer H., Kus M.L., Blake D.R., Morris C.J. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1993, 51:677-707.
54. Toshniwal P.K., Zarling E.J. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem Res 1992, 17:205-207.